Wartofsky Leonard, Van Nostrand Douglas, Burman Kenneth D
Uniformed Services University, Bethesda, Maryland, USA.
Obstet Gynecol Surv. 2006 Aug;61(8):535-42. doi: 10.1097/01.ogx.0000228778.95752.66.
Thyroid disease in general, and hypothyroidism in particular, are very common in women. In the USA, the most common cause of primary thyroid deficiency is on an autoimmune basis due to lymphocytic (Hashimoto) thyroiditis. Because there are thyroid hormone receptors in virtually every tissue of the body, the manifestations of hypothyroidism are varied, but problems with abnormal menses, conception, fertility, and pregnancy can be especially troubling in young women. The single most important diagnostic test is measurement of serum thyrotropin (TSH). The overwhelming majority of patients with hypothyroidism are treated with a single daily dose of synthetic levothyroxine with the goal of therapy being restoration of a normal metabolic state with return of the TSH level down to the range of 0.5 to 1.5 mlU/L. "Subclinical" hypothyroidism refers to those patients with early or mild thyroid hypofunction manifested as slight elevations of thyrotropin (approximately 4-10 mlU/L) although serum thyroxine (T4) and triiodothyronine (T3) levels are within their reference ranges. The entity is somewhat controversial in regard to its consequences if left untreated, and whether or not we should be screening patients, at least susceptible populations, for the condition. Reports indicate an association between subclinical hypothyroidism and poor outcomes of pregnancy, as well as dyslipidemias, atherogenesis, and increased mortality in the long term. We believe these consequences are sufficiently compelling to warrant screening and treatment with levothyroxine when found to halt progression to overt hypothyroidism, and improve symptoms, pregnancy outcomes, lipid abnormalities, and cardiovascular function.
Obstetricians & Gynecologists, Family Physicians.
After completion of this article, the reader should be able to recall that hypothyroidism is a common disease in women, has many protean manifestations, and can be successfully diagnosed and treated; explain that the condition of subclinical hypothyroidism can be diagnosed and if treated can prevent many untoward complications; and state that there should be heightened awareness of the disease so that proper screening tests can be performed.
甲状腺疾病总体上,尤其是甲状腺功能减退症,在女性中非常常见。在美国,原发性甲状腺功能减退最常见的病因是基于自身免疫,由淋巴细胞性(桥本)甲状腺炎引起。由于甲状腺激素受体几乎存在于身体的每个组织中,甲状腺功能减退的表现多种多样,但月经异常、受孕、生育和妊娠问题在年轻女性中可能尤其令人困扰。最重要的单项诊断检查是测定血清促甲状腺激素(TSH)。绝大多数甲状腺功能减退患者接受每日一次的合成左甲状腺素治疗,治疗目标是恢复正常代谢状态,使TSH水平降至0.5至1.5 mIU/L范围内。“亚临床”甲状腺功能减退症是指那些甲状腺功能早期或轻度减退的患者,表现为促甲状腺激素轻度升高(约4 - 10 mIU/L),尽管血清甲状腺素(T4)和三碘甲状腺原氨酸(T3)水平在其参考范围内。关于该病症若不治疗的后果以及我们是否应该对患者,至少是易感人群进行筛查,这一实体存在一定争议。报告表明亚临床甲状腺功能减退症与妊娠不良结局、血脂异常、动脉粥样硬化以及长期死亡率增加之间存在关联。我们认为这些后果足以令人信服,当发现亚临床甲状腺功能减退症时,进行筛查并用左甲状腺素治疗以阻止进展为显性甲状腺功能减退症,并改善症状、妊娠结局、脂质异常和心血管功能是有必要的。
妇产科医生、家庭医生。
阅读本文后读者应能够记住甲状腺功能减退症是女性常见疾病,有多种表现形式,可成功诊断和治疗;解释亚临床甲状腺功能减退症可被诊断,若接受治疗可预防许多不良并发症;并指出应提高对该疾病的认识以便能进行适当的筛查检查。